Stroke Risk Up After Cancer Diagnosis

Cancer increases the risk of stroke independently of other stroke risk factors, such as hypertension and diabetes.

Looking for a Job?

Access our job board to view over 1,​40​0 job openings throughout the US.

Proton Pump Inhibitors, Gastric Pre-Cancerous Lesions

It has been suggested that long-term use of proton pump inhibitors (PPIs) may promote the development of pre-cancerous lesions in the stomach and increase the occurrence of stomach cancer.

Vaccine Could Prevent Most Cervical Cancers

A vaccine meant to protect against nine types of human papillomavirus (HPV) could prevent 90% of all cervical cancers.

Obese CRC Patients, Second Cancer Risk

Colorectal cancer (CRC) patients who are overweight or obese when diagnosed appear to face a slightly higher risk for developing a second weight-related cancer.

ASTRO: New Choosing Wisely Guidelines

The American Society for Radiation Oncology (ASTRO) has released a second list of five radiation oncology-specific treatments that should be discussed before being prescribed.

Yogurt Test as Novel Colonoscopy Alternative ...

Synthetic biomarkers combined with yogurt may one day replace or augment colonoscopies and improve early diagnosis of colorectal cancer.

Prostate Cancer Treatments

Review this new chart on FDA-approved prostate cancer treatments for quick information when you need it.

News

L858R Mutation in Circulating Free DNA Is Prognostic in NSCLC

L858R Mutation in Circulating Free DNA Is Prognostic in NSCLC

L858R mutation in tumor tissue or cfDNA is marker of shorter overall, progression-free survival

Oral Bisphosphonate Use May Lower Endometrial Cancer Risk

Oral Bisphosphonate Use May Lower Endometrial Cancer Risk

Reduction in endometrial cancer risk with ever use in large cohort of postmenopausal women

Genetic Mutations Linked to Leukemia: Inevitable Part of Aging?

Genetic Mutations Linked to Leukemia: Inevitable Part of Aging?

For many people an increase in genetic mutations that could trigger leukemia seems to be an inevitable part of aging, but just having cancer-linked DNA doesn't mean the disease will develop.

Lenvima Now Available Through Specialty Pharmacies

Lenvima Now Available Through Specialty Pharmacies

Lenvima (lenvatinib; Eisai) is now available through two specialty pharmacies, Accredo and Biologics Inc. for the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC).

Prognosis With Ibrutinib Discontinuation in CLL Identified

Prognosis With Ibrutinib Discontinuation in CLL Identified

For patients with chronic lymphocytic leukemia (CLL), the Bruton tyrosine kinase (BTK) inhibitor ibrutinib is effective, and prognosis is poor after discontinuation.

Charts

Make prescribing decisions with our comparative charts and treatment algorithms.

Patient Information Fact Sheets

Download or print easy-to-read disease leaflets for your patients.

Featured courses from myCME

Chronic Pain ManagementExternal web site

This activity is designed to change health provider attitudes on chronic pain and willingness to ...

CME|CE 2.00 Credits

The Brigham Board Review in Hematology and OncologyExternal web site

The Brigham Board Review in Hematology and Oncology offers expert preparation for your ABIM subspecialty ...

CME 42.00 Credits

Sign Up for Free e-newsletters